Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial
Letter
[키워드] 1:1
Adverse reaction
age
allergy
Anti-inflammatory
Antibody test
anticipated
antiviral therapy
assigned
Bandar Abba
Bandar Abbas
Blinding
Breastfeeding
C-reactive protein
Chest computed tomography
chronic heart disease
clinical
clinical study
clinical symptom
Clinical symptoms
clinical trial
company
conducted
Confirmed
Control
control group
Corticosteroids
COVID-19
criteria
Critical
diagnosis of SARS-CoV-2
Diseases
disorders
dissemination
diuretics
dose
drugs
dry cough
education
Effect
element
evaluated
feature
Features
female patient
Fever
glycyrrhiza
history
hospital
Hospitalization
hypertension
ill patient
incidence
Infection
inhibitor
intervention group
Iran
Laboratory
Laboratory signs
licorice
liquorice
liver
lymphocytopenia
male
Medical Sciences
Ministry of Health
Moderate COVID-19
number
objective
Open-label
outcome
parallel-group
participant
Patient
pharmaceutical
Placebo
Pneumonia
polymerase chain
Primary outcome
protocol
random
randomization
randomize
Randomized
Randomized controlled trial
regimen
Registered
registry
renal
Sample size
screened
secondary outcome
selective
serotonin reuptake inhibitor
Seven
single-center
standard treatment
status
Study protocol
therapeutic
Thyroid
time
tiredness
Treatment
treatment arm
Trial
university
Version
website
X-ray
[DOI] 10.1186/s13063-020-04706-3 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04706-3 PMC 바로가기 [Article Type] Letter